NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/03/2023
Voltar para busca
Dado oficial do USPTO
LIAISON IQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LIAISON IQ
ST13
US500000097074035Classe
1, 5, 9, 10
Pedido
97074035
Registro
7003667
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
21/03/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
14/10/2021
Data de registro
21/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/03/2023
Última transação
21/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
09
Localização do titular
SALUGGIA, VERCELLI, IT
Examinador
SALES, HEATHER
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DIASORIN S.P.A.
DIASORIN INC.
Representantes
Jeffrey B. Sladkus, Esq. THE SLADKUS LAW GROUP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in science; chemical diagnostic reagents for scientific purposes; Diagnostic preparationsother than for medical or veterinary purposes; diagnostic substancesother than for medical or veterinary use; Reagent bearing diagnostic strips for testing of infectious diseases and organic moleculesother than for medical or veterinary use; diagnostic testing materialsother than for medical use in the nature of reagent bearing diagnostic strips for testing saliva; Control preparationschemical control solutions used in in-vitro diagnostic testingscreeningconfirmation and analysis for laboratory or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical control solutions used in diagnostic test kits for laboratory or research purposes; chemically treated non-medical test strips for laboratory or research purposes; diagnostic preparations for laboratory or research use; diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; diagnostic biomarkers for analyticalresearch and scientific use; diagnostic preparations for in vitro testing for scientific use
Classe 5
Diagnostic preparations for medical and veterinary purposes; Medical diagnostic test reagents for testing body fluids for veterinary use; medical diagnostic test reagents for testing body fluids for medical purposes; Diagnostic agents for medical use; Chemical reagents for medical or veterinary purposes; diagnostic kits comprising medical diagnostic bioreagents for extractingtesting and analyzing body fluids; diagnostic test kits comprising medical diagnostic reagents and assays for testing of bodily fluids for use in diseases detectioninfectious diseases and detection of biological parameters; Diagnostic testing materials for medical usemedical diagnostic test strips for use in the field of infectious deseases and detection of biological parameters; medical diagnostic test strips for blood analysis; virus testing preparations for medical use; medical diagnostic assays for medical use; in vitro medical diagnostic teststest strips; in vitro medical diagnostic assays for medical use; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; in vitro medical diagnostic test strips for blood analysis; in vitro medical diagnostic reagents; medical diagnostics tests strips for the detectiondiagnosisscreeningconfirmation of viruses and infections; reagents and test strips for medical purposes for use in detecting the presence of nucleic acid targetsindicators of diseasessuch indicators including enzymesantigensantibodies and nucleic acids; immunoassay reagents for medical use; biochemical preparations for medical or veterinary purposes for detection of infectious diseases and biological parameters; bacterial preparations for medical and veterinary use
Classe 9
Downloadable computer software mobile applications for use in diagnosing individuals; downloadable computer software for medical diagnostics and for use to operate diagnostic apparatuses not for medical purpose; downloadable portable and cloud-connected POC (Point of care) immunodiagnostic software platform for diagnosing individuals; Downloadable computer software and hardware for the designcreation and control of tools for medical diagnosticsdata-processing softwareapparatusequipmenthardware and computers for diagnostics; data storageprocessing and transmission apparatus for diagnostic purposeblank tapes for storage of computer data; electronic book readers for diagnostic purpose; PC tablets used for test and diagnostic purpose; Video monitors; structural parts and fittings for the aforementioned goods where applicableall applied in the diagnostic field; Testing apparatus not for medical purposesapparatus for testing liquids and solids; testing machines and instruments for diagnostic purposeother than for medical useapparatus for testing liquids and solidscomposed of PC tablets and optical reader; research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids
Classe 10
Diagnostic testing apparatus for medical purposes for testing biomarkers and other biomolecules; medical diagnostic apparatus for medical purposes; tools for medical diagnosticsmedical diagnostic apparatus for testing for viruses and infection diseases; medical devices for diagnosing viruses; medical testing equipmentmedical device for detecting antibodies against SARS-CoV-2; medical apparatus for use in medical analysis for analyzing bacteria; Electronic analyzers for bacterial identification for medical purposes; apparatus for taking blood samples; apparatus for taking body fluid samples; Point of Care (POC) diagnosticexaminationmonitoring equipmentrespiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for medical purposes; diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2 in capillary blood samples; medical diagnostic apparatus for the identification of antigens to diagnose Covid-19 via nasal swab; diagnostic apparatus for the identification of virus and infectious diseases; radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; medical diagnostic apparatus for testing for viruses; apparatus for DNA and RNA testing for medical purposes; Syringes for injections; syringes for medical purposes; hypodermic syringes; extraction medical syringes; disposable hypodermic syringes for medical use; medical syringe needles; needles for medical purposes; medical micro-needling devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
21/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2023
PUBO
PUBLISHED FOR OPPOSITION
03/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
18/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
18/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/10/2022
ALIE
ASSIGNED TO LIE
19/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/03/2022
GNRT
NON-FINAL ACTION E-MAILED
16/03/2022
CNRT
NON-FINAL ACTION WRITTEN
16/03/2022
DOCK
ASSIGNED TO EXAMINER
15/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2021
NWAP
NEW APPLICATION ENTERED
18/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIAISON IQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.